Back to search

Article

Molecular aging is the main driver of Parkinson’s Disease

2025-08-30

Abstract excerpt

Aging as well as the presence of α-synuclein (α-syn) oligomers in the brain are indisputably linked to Parkinson’s disease (PD). A central concept of geroscience is that the biological processes of aging drive the onset of aging-associated diseases. The extent to which the biological processes of aging directly contribute to PD and the inter-relationship with α-syn oligomers for the onset of PD symptoms remains un...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bed3c1df-3ef5-5779-80df-b037e46e8d7a
DOI
10.1101/2025.08.27.672359
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Molecular aging is the main driver of Parkinson’s DiseaseDOI 10.1101/2025.08.27.672359
Targeting CDC42 with CASIN Reprograms Cell Type Specific Transcriptomes and MAPK Driven Transcription Factor Networks in the Aging BrainSemantic proximity
A new synuclein-transgenic mouse model for early Parkinson’s reveals molecular features of preclinical diseaseSemantic proximity
Longitudinal multi-omics in alpha-synuclein Drosophila model discriminates disease- from age-associated pathologies in Parkinson’s diseaseSemantic proximity
A New Synuclein-Transgenic Mouse Model for Early Parkinson's Reveals Molecular Features of Preclinical Disease.Semantic proximity
GLP-1 analogs restore inflammatory, mitochondrial and intercellular signaling networks in the <i> Snca <sup>G51D/G51D</sup> </i> knock-in mouse model of Parkinson’s diseaseSemantic proximity
Spreading alpha-synuclein Oligomers Trigger Astrocyte Changes and Astrocyte-Glutamatergic Neuron system dysfunction in an Age-related MannerSemantic proximity
Deregulation of α-synuclein in Parkinson’s disease: Insight from epigenetic structure and transcriptional regulation of SNCASemantic proximity
α-Synuclein, Parkinson's disease, and Alzheimer's diseaseSemantic proximity
α-synuclein aggregation reduces nigral myocyte enhancer Factor-2D in idiopathic and experimental Parkinson's diseaseSemantic proximity
Inhibition of α-synuclein aggregation by MT101-5 is neuroprotective in mouse models of Parkinson’s diseaseSemantic proximity
REST Protects Dopaminergic Neurons from Mitochondrial and α-Synuclein Oligomer Pathology in an Alpha Synuclein Overexpressing BAC-Transgenic Mouse ModelSemantic proximity
E46K mutant α-synuclein is more degradation resistant and exhibits greater toxic effects than wild-type α-synuclein in Drosophila models of Parkinson's diseaseSemantic proximity
Select a neighboring publication to make it the new centre.